Replies to post #1520 on Anavex Life Sciences Corp (AVXL)

[jbem777]

Time and lack of interest. Clinical trials and development take time in biotech and there is always money to be made elsewhere. Now we have upcoming catalysts and the interest will follow driving us to new highs.

[joey67]

Welcome to AVXL. It's because just like most companies, it takes years, sometimes decades to become established with a viable product. Back in 2011, i think it was february 2011, Dr. Aisen was just being appointed to the advisory board. Often times, when new companies are starting out, the PPS starts off high and then works its way down until the years of preparation begin to show results. For yourself, you would be getting into AVXL at a great period of time. Instead of waiting all of those past years, watching the PPS drop, you would be entering at the pivotal point when all these years of preparation are about to show their fruit. Back in 2011, AVXL was nowheres near phase 2a. Now they are about to surpass 2a; which is why the PPS has stopped declining and is leveling off.
Dont be intimidated by the drastic decline of share price. By itself, PPS means absolutely nothing. AVXL always reports on time, and is very good at not leaving their investors in the dark.

If youre new to stocks, id suggest reading about 'Support and resistance'. AVXL is showing clear signs in these recent days. Also, do your DD and read up on the many SEC filings.

A SEC filing from december 2013 reads,

"The Company plans to continue human clinical trials, among them a multiple ascending dose study of ANAVEX 2-73 and ANAVEX PLUS and a Phase 2 thereafter in the first half of fiscal year 2014".

this is the great thing about AVXL. Theyre always on time with their plans and work very hard at accomplishing their goals. Slow and steady wins the race. My timeline for AVXL to really push forward has been and remains 7 years. 3 more to go.

[ValueTrader5]

Because they're a small company working on a MAJOR drug in a absolutely booming alz business and they don't pump or manipulate with flimsy PRs so shortys and MMs brought it down .. Could be best sustainable otc play of the year imo

LONG AVXL